2024-10-19 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Analysis Report 

**Company Overview:** Intuitive Surgical Inc. is a leading provider of robotic-assisted minimally invasive surgery systems.

**1. Performance Comparison:**

* **Cumulative Return:** ISRG has delivered a cumulative return of 377.54%, significantly outperforming the S&P 500 (VOO) with a cumulative return of 137.88%.
* **Relative Performance:**  ISRG's performance has been consistently strong, currently showing a relative outperformance of 239.66 compared to the S&P 500. This places ISRG in the 82.52 percentile of its historical performance range against the benchmark.

**2. Recent Price Movement:**

* **Closing Price:** $521.15
* **5-day Moving Average:** $487.51
* **20-day Moving Average:** $485.04
* **60-day Moving Average:** $477.13

The stock price is currently trading above its short-term and long-term moving averages, indicating potential upward momentum.

**3. Technical Indicators:**

* **RSI:** 62.74, indicating a moderately overbought condition, but not yet a strong sell signal.
* **PPO:** 0.3, suggesting positive momentum.
* **Delta_Previous_Relative_Divergence:**  6.75 (+), showing a short-term upward trend.
* **Expected_Return:** 5.4%, representing the anticipated long-term (2 years+) outperformance against the S&P 500.

These indicators suggest a positive outlook for ISRG in the short-to-medium term.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-10-18 | 1.59 | 2.04 B$ |
| 2024-07-19 | 1.48 | 2.01 B$ |
| 2024-04-19 | 1.54 | 1.89 B$ |
| 2023-10-20 | 1.18 | 1.74 B$ |
| 2024-10-18 | 1.18 | 1.74 B$ |

ISRG has consistently exceeded analysts' earnings estimates in recent quarters, demonstrating strong revenue growth. 

**5. News and Recent Issues:**

* **Recent Market Outlook:** ISRG continues to benefit from the growing demand for minimally invasive surgical procedures. 
* **Analyst Opinions:** The majority of analysts maintain a bullish outlook on ISRG, citing its strong market position, innovative technology, and continued growth potential.
* **Performance Highlights:** ISRG's recent product launches and strategic partnerships have been well-received by the market, further strengthening its competitive advantage.

**6. Comprehensive Analysis:**

ISRG exhibits a strong track record of performance, outperforming the S&P 500 significantly. Recent price action, technical indicators, and earnings performance all point towards a positive outlook. The company continues to innovate and expand its market share in the rapidly growing robotic surgery market.

**7. Conclusion:**

ISRG is a solid investment with a strong track record and promising growth prospects. While the current RSI indicates a moderately overbought condition, the positive technical indicators, recent earnings performance, and favorable market outlook suggest further upside potential for the stock. 
